摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tetrakis-O-(diethoxyphosphoryl)-p-tert-butylcalix[4]arene | 128910-40-7

中文名称
——
中文别名
——
英文名称
tetrakis-O-(diethoxyphosphoryl)-p-tert-butylcalix[4]arene
英文别名
25,26,27,28-tetrakis-O-(diethoxyphosphoryl)(p-tert-butyl)calix[4]arene;Diethyl [5,11,17,23-tetratert-butyl-26,27,28-tris(diethoxyphosphoryloxy)-25-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl] phosphate
tetrakis-O-(diethoxyphosphoryl)-p-tert-butylcalix[4]arene化学式
CAS
128910-40-7
化学式
C60H92O16P4
mdl
——
分子量
1193.28
InChiKey
ZWBGNSWYZHTNCY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    15
  • 重原子数:
    80
  • 可旋转键数:
    28
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    179
  • 氢给体数:
    0
  • 氢受体数:
    16

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Selectively dehydroxylated calix[4]arenes and 1,3-dithiocalix[4]arenes; novel classes of calix[4]arenes
    作者:Yuhua Ting、Willem Verboom、Leo C. Groenen、Jan-Dirk van Loon、David N. Reinhoudt
    DOI:10.1039/c39900001432
    日期:——
    Selective modification of calix[4]arenes either by selective dehydroxylation via the reductive removal of phosphate(s), or via the Newman–Kwart rearrangement of 1,3-bis(dimethylthiocarbamoyl)calix[4]arenes yields calix[4]arenes 3 and 1,3-dithiocalix[4]arenes 6, respectively.
    杯[4]芳烃的选择性修饰,可以通过磷酸盐的还原去除或通过1,3-双二甲基硫基甲酰基)杯[4]芳烃的Newman-Kwart重排而进行选择性羟基,从而产生杯[4]芳烃3和1,3-二杂杯[4]芳烃6。
  • Symmetrical and inherently chiral water-soluble calix[4]arenes bearing dihydroxyphosphoryl groups
    作者:Maxim A. Tairov、Myroslav O. Vysotsky、Olga I. Kalchenko、Vladimir V. Pirozhenko、Vitaly I. Kalchenko
    DOI:10.1039/b110691k
    日期:2002.5.23
    A series of symmetrical and inherently chiral water-soluble calix[4]arenes bearing one, two or four proton-ionisable dihydroxyphosphoryl groups at the narrow rim of the macrocycle has been synthesised by consecutive treatment of appropriate diethoxyphosphoryl derivatives with bromotrimethylsilane and methanol. The calix[4]arene phosphoric acids synthesised possess pKa-values 2.85–3.10 (CH3OH–H2O 70 : 30) and form salts with L-(−)-α-phenylethylamine or (1S,2R)-(+)-ephedrine in methanol solution. The salts of the inherently chiral calixarene phosphoric acids with chiral amines are easily separated into diastereomeric forms by the RP HPLC method on Separon SGX C18 or Partisil 5 ODS 3 achiral columns.
    通过用化三甲基硅烷甲醇连续处理适当的二乙生物,合成了一系列对称的、固有手性的溶性[4],这些[4]在大环的窄边上带有一个、两个或四个可质子离子化的二羟基基。合成的[4]炔磷酸的 pKa 值为 2.85-3.10(CH3OH-H2O 70:30),并在甲醇溶液中与 L-(-)-α-苯乙胺或 (1S,2R)-(+)-麻黄碱形成盐。在 Separon SGX C18 或 Partisil 5 ODS 3 非手性色谱柱上采用 RP HPLC 方法,可以轻松地将固有手性的磷酸盐与手性胺分离成非对映异构体。
  • Phosphorylated-calix[4]arene double-deckers of single rare earth metal ions
    作者:Marjan Hosseinzadeh、Sergio Sanz、Jan van Leusen、Natalya V. Izarova、Euan K. Brechin、Scott J. Dalgarno、Paul Kögerler
    DOI:10.1039/d1cc02910j
    日期:——
    Combination of phosphoryl and calix[4]arene moieties in the same organic framework (LPO) directs the formation of homoleptic double–decker complexes [LnIII(LPO)2](OTf)3 for Ln = Tb and Dy, with the latter displaying slow relaxation of the magnetisation.
    酰基和杯[4]芳烃部分在同一有机骨架 (L PO ) 中的组合指导形成均配双层复合物 [Ln III (L PO ) 2 ](OTf) 3,其中 Ln = Tb 和 Dy,其中后者显示出磁化的缓慢弛豫。
  • Phase Solubility Studies of Poorly Soluble Drug Molecules by Using <i>O</i>-Phosphorylated Calixarenes as Drug-Solubilizing Agents
    作者:Mevlüt Bayrakcı、Şeref Ertul、Mustafa Yilmaz
    DOI:10.1021/je200992c
    日期:2012.1.12
    This study is the first report on the solubilizing effect of O-phosphorylated calix[n]arenes that form complexes with neutral molecules such as nifedipine, niclosamide, and furosemide by host-guest complexation. These complexation studies were carried out by using the phase solubility technique. From the obtained results, it was observed that the solubility of guest molecules such as nifedipine, niclosamide, and furosemide was significantly increased in the presence of host molecules tetrakis-O-(diethoxyphosphoryl)-p-tert-butylcalix[4]arene (1), tetrakis-O-(diethoxyphosphoryl)-calix[4]arene (2), bis-O-(diethoxyphosphoryl)-p-tert-butylcalix[4]arene (3), bis-O-(diethoxyphosphoryl)-calix[4]arene (4), and octakis-O-(diethoxyphosphoryl)-p-tert-butylcalix[8]arene (5). The increase in solubility of drugs by the calixarene host 1 to 5 was most probably due to inclusion complexation between drug molecules and cavities of the calixarene skeleton similar to drug-cyclodextrin complexes.
  • Harrowfield, Jack M.; Mocerino, Mauro; Peachey, Brendan J., Journal of the Chemical Society, Dalton Transactions, 1996, p. 1687 - 1700
    作者:Harrowfield, Jack M.、Mocerino, Mauro、Peachey, Brendan J.、Skelton, Brian W.、White, Allan H.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-盐酸沙丁胺醇 (S)-溴烯醇内酯 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-3,3''-双([[1,1''-联苯]-4-基)-[1,1''-联萘]-2,2''-二醇 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-2,2'',3,3''-四氢-6,6''-二-9-菲基-1,1''-螺双[1H-茚]-7,7''-二醇 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (6,6)-苯基-C61己酸甲酯 (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,5R)-3,3a,8,8a-四氢茚并[1,2-d]-1,2,3-氧杂噻唑-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aS,8aR)-2-(吡啶-2-基)-8,8a-二氢-3aH-茚并[1,2-d]恶唑 (3aS,3''aS,8aR,8''aR)-2,2''-环戊二烯双[3a,8a-二氢-8H-茚并[1,2-d]恶唑] (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (3S,3aR)-2-(3-氯-4-氰基苯基)-3-环戊基-3,3a,4,5-四氢-2H-苯并[g]吲唑-7-羧酸 (3R,3’’R,4S,4’’S,11bS,11’’bS)-(+)-4,4’’-二叔丁基-4,4’’,5,5’’-四氢-3,3’’-联-3H-二萘酚[2,1-c:1’’,2’’-e]膦(S)-BINAPINE (3-三苯基甲氨基甲基)吡啶 (3-[(E)-1-氰基-2-乙氧基-2-hydroxyethenyl]-1-氧代-1H-茚-2-甲酰胺) (2′′-甲基氨基-1,1′′-联苯-2-基)甲烷磺酰基铝(II)二聚体 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,4S)-Fmoc-4-三氟甲基吡咯烷-2-羧酸 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环